from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0781/ptrBa

LFCtreatmentdescriptionclass of inhibitor

-0.431

Amikacinug/mL Amikacintranslation

0.080

Cap5-10ug/mL Capreomycintranslation

-0.330

Rox10-50 ug/mL Roxithromycintranslation

0.665

SM2-5 ug/mL Streptomycintranslation

-2.966

Tet5-10 ug/mL Tetracyclinetranslation

-0.703

Rif0.2-5ug/mL Rifampicintranscription

-0.061

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.652

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.578

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.096

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.161

Clofazimine10-13 ug/mL Clofaziminerespiration

0.649

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.406

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.744

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.510

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.394

Econazole10-24 ug/mL Econazole (azole drug)respiration

-2.054

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.030

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.485

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.123

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.045

KCN5-20 ug/mL Potassium cyaniderespiration

0.216

NaN30.2-2 mM Sodium aziderespiration

1.818

Nigericin50 uM Nigericinrespiration

-0.594

TRC10-150 ug/mL Triclosanrespiration

-1.201

TRZ10-25 ug/mL Thioridazinerespiration

0.020

Valinomycin0.5-10 uM Valinomycinrespiration

1.614

ZnSO42 mM ZnSO4respiration

-0.252

menadione6-10 ug/mL Menadionerespiration

-0.507

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.775

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.008

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.723

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.136

NRP_1Non-replicating persistence stage 1dosRassociated

0.753

Amp0.2mg/mL AmpicillincellWall

0.539

Cephalexin20-100 ug/mL CephalexincellWall

0.951

Cerulenin0.32-5 ug/mL CerulenincellWall

0.767

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.536

EMB10-20 ug/mL EthambutolcellWall

0.840

Eta12-40 ug/mL EthionamidecellWall

0.619

INH0.2-0.4 ug/mL IsoniazidcellWall

0.409

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.057

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.575

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.221

BZA0.12 mg/mL BenzamidearomaticAmides

-0.350

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.084

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.558

H2O24 mM hydrogen peroxideDNAdamaging

0.318

Levo10 ug/mL LevofloxacinDNAdamaging

0.390

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.558

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.739

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.492

UVUV-irradiationDNAdamaging

-0.421

ARP41-4 ug/mL Antitubercular compound ARP4?

0.984

Antimycin12.5-50 ug/mL Antimycin A?

0.666

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.965

PA_110-50 ug/mL Antitubercular compound PA-1?

0.876

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.988

PA8240.2-2 ug/mL PA-824?

-0.249

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.393

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.563

Verapamil50 uM Verapamil?

0.822

mercaptoethanol2 mM 2-Mercaptoethanol?

0.979

methoxatin10-20 ug/mL Methoxatin?